These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3139897)

  • 1. Bilateral upper extremity ischemia after administration of dihydroergotamine-heparin for prophylaxis of deep venous thrombosis.
    Seifert KB; Blackshear WM; Cruse CW; Schwartz JA; Suslavitch F
    J Vasc Surg; 1988 Oct; 8(4):410-4. PubMed ID: 3139897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arterial vasospasm as a complication of the prevention of thromboembolism with heparin-dihydroergotamine and its treatment].
    Schott G; Riedel K
    Zentralbl Chir; 1986; 111(21):1354-7. PubMed ID: 3101315
    [No Abstract]   [Full Text] [Related]  

  • 3. Vascular spasm and gangrene during heparin-dihydro-ergotamine prophylaxis.
    Cunningham M; de Torrenté A; Ekoé JM; Ackermann JP; Humair L
    Br J Surg; 1984 Nov; 71(11):829-31. PubMed ID: 6498453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Arterial spasm caused by administration of DHE-heparin in a tibial fracture].
    Hertz H; Wruhs O; Polterauer P
    Aktuelle Traumatol; 1984 Aug; 14(4):142-5. PubMed ID: 6147974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible vasospasm in association with the use of heparin and dihydroergotamine.
    Bachner EJ; Konsens RM; Priem L; King T; Froimson AI
    Clin Orthop Relat Res; 1992 Oct; (283):261-4. PubMed ID: 1395256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydroergotamine-heparin to prevent postoperative deep vein thrombosis.
    Med Lett Drugs Ther; 1985 May; 27(688):45-6. PubMed ID: 3889570
    [No Abstract]   [Full Text] [Related]  

  • 7. St. Anthony's fire: successful reversal of ergotamine-induced peripheral vasospasm by hydrostatic dilatation.
    Baader W; Herman C; Johansen K
    Ann Vasc Surg; 1990 Nov; 4(6):597-9. PubMed ID: 2261328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe vasospastic reactions (ergotism) during prophylactic administration of heparin-dihydroergotamine.
    Bounameaux H; Schneider PA; Mossaz A; Suter P; Vasey H
    Vasa; 1987; 16(4):370-2. PubMed ID: 3424957
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vasospastic reactions to heparin-dihydergot].
    Majer M; Wierichs R
    Dtsch Med Wochenschr; 1983 Apr; 108(16):640. PubMed ID: 6839987
    [No Abstract]   [Full Text] [Related]  

  • 10. Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis.
    Kakkar VV; Stringer MD; Hedges AR; Parker CJ; Welzel D; Ward VP; Sanderson RM; Cooper D; Kakkar S
    Am J Surg; 1989 Apr; 157(4):413-8. PubMed ID: 2539025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial.
    Beisaw NE; Comerota AJ; Groth HE; Merli GJ; Weitz HH; Zimmerman RC; Diserio FJ; Sasahara AA
    J Bone Joint Surg Am; 1988 Jan; 70(1):2-10. PubMed ID: 3275673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thromboembolism prevention in surgical medicine: heparin or heparin-dihydroergotamine?].
    Rasche H; Vollmar J; Burri C; Beger HG; Kilian J; Kinzl J; Krautzberger W; Wenzke C
    Langenbecks Arch Chir; 1983; 360(2):81-95. PubMed ID: 6355715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ergotism of the lower extremities resulting from thrombosis prevention using DHE-heparin. An angiographic follow-up study].
    Warmuth-Metz M
    Radiologe; 1988 Oct; 28(10):491-3. PubMed ID: 3186973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute ischemia due to vasospasm following prevention of thrombosis with dihydroergotamine/heparin].
    Meybier H; Krämer KL; Maeder N; Kretzschmar U; Allenberg JR
    Rontgenpraxis; 1987 Aug; 40(8):287-94. PubMed ID: 3660102
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effectiveness-risk ratio of heparin-dihydroergotamine].
    Kakkar VV
    Dtsch Med Wochenschr; 1983 Oct; 108(40):1536-7. PubMed ID: 6617512
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnosis and therapy of ergotism following the use of heparin-DHE in thrombosis prevention].
    Wiesmann W; Peters PE; Irskens U; Schwering H
    Rofo; 1987 Oct; 147(4):446-9. PubMed ID: 2825270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory vasospasm occurring in a trauma patient receiving dihydroergotamine and heparin.
    Shackford SR; Davis JW
    Crit Care Med; 1988 Sep; 16(9):909-10. PubMed ID: 3402234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of dihydroergotamine and heparin in the prophylaxis of deep venous thrombosis.
    Comerota AJ; White JV
    Chest; 1986 May; 89(5 Suppl):389S-395S. PubMed ID: 3698718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the prophylaxis of deep venous thrombosis: a profile of embolex. Proceedings of a scientific symposium. May 3, 1985, New York City.
    Pharmacotherapy; 1986; 6(4 Pt 2):1S-29S. PubMed ID: 3774564
    [No Abstract]   [Full Text] [Related]  

  • 20. [Angiospasm and dihydroergotamine--dangers in thromboprevention].
    Schwering H; Rühland D
    Zentralbl Chir; 1985; 110(18):1115-21. PubMed ID: 4082802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.